USANA Health Sciences, Inc.
USNANYSEConsumer Defensive● Active
$18.70
+$0.67(+3.72%)
Market Cap$345258306
P/E Ratio—
52W High$38.32
52W Low$16.6
USANA Health Sciences, Inc. (USNA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
USNA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.61
Est. $0.44 · +38.6%
Revenue
$0.25B
Est. $0.24B · +3.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
USNA reports quarterly as a NYSE-listed Packaged Foods company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $0.43 | — | — | — | $0.24B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $0.44 | $0.61 | +38.6% | $0.25B | $0.24B | +3.7% |
| ▲ Q1 FY2026 | Feb 17, 2026 | $0.41 | $0.60 | +46.3% | $0.23B | $0.23B | +0.1% |
| ▼ Q4 FY2025 | Oct 21, 2025 | $0.25 | -$0.15 | -160.0% | $0.21B | $0.22B | -2.8% |
| ▲ Q3 FY2025 | Jul 22, 2025 | $0.54 | $0.74 | +37.0% | $0.24B | $0.23B | +4.4% |
| ▲ Q2 FY2025 | Apr 22, 2025 | $0.70 | $0.73 | +4.3% | $0.25B | $0.22B | +13.2% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $0.49 | $0.64 | +30.6% | $0.21B | $0.21B | +2.3% |
| ▲ Q4 FY2024 | Oct 22, 2024 | $0.49 | $0.56 | +14.3% | $0.20B | $0.21B | -4.1% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$0.43
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.61
EPS Est.
$0.44
EPS Surpr.
+38.6%
Revenue
$0.25B
Q1 FY2026
Feb 17, 2026Beat
EPS Actual
$0.60
EPS Est.
$0.41
EPS Surpr.
+46.3%
Revenue
$0.23B
Q4 FY2025
Oct 21, 2025Miss
EPS Actual
-$0.15
EPS Est.
$0.25
EPS Surpr.
-160.0%
Revenue
$0.21B
Q3 FY2025
Jul 22, 2025Beat
EPS Actual
$0.74
EPS Est.
$0.54
EPS Surpr.
+37.0%
Revenue
$0.24B
Q2 FY2025
Apr 22, 2025Beat
EPS Actual
$0.73
EPS Est.
$0.70
EPS Surpr.
+4.3%
Revenue
$0.25B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.64
EPS Est.
$0.49
EPS Surpr.
+30.6%
Revenue
$0.21B
Q4 FY2024
Oct 22, 2024Beat
EPS Actual
$0.56
EPS Est.
$0.49
EPS Surpr.
+14.3%
Revenue
$0.20B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.75 | $0.75 | $0.75 | 1 |
| Q4 FY2027 | $0.74 | $0.74 | $0.74 | 1 |
| Q3 FY2027 | $0.65 | $0.65 | $0.65 | 1 |
| Q2 FY2027 | $0.64 | $0.64 | $0.64 | 1 |
| Q1 FY2027 | $0.65 | $0.65 | $0.65 | 1 |
| Q4 FY2026 | $0.43 | $0.43 | $0.43 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +38.6% | $18.56 | $19.26 | +3.77% |
| ▲ Q1 FY2026 | Feb 17, 2026 | +46.3% | $20.90 | $20.66 | -1.15% |
| ▼ Q4 FY2025 | Oct 21, 2025 | -160.0% | $20.68 | $21.03 | +1.69% |
| ▲ Q3 FY2025 | Jul 22, 2025 | +37.0% | $30.29 | $31.53 | +4.09% |
| ▲ Q2 FY2025 | Apr 22, 2025 | +4.3% | $23.83 | $24.24 | +1.72% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +30.6% | $32.69 | $31.96 | -2.23% |
| ▲ Q4 FY2024 | Oct 22, 2024 | +14.3% | $35.05 | $34.48 | -1.63% |
| ▼ Q3 FY2024 | Jul 23, 2024 | -16.9% | $46.20 | $45.96 | -0.52% |
Q2 FY2026+3.77%
Report Date
May 5, 2026
EPS Beat/Miss
+38.6%
Price Before
$18.56
Price After
$19.26
Q1 FY2026-1.15%
Report Date
Feb 17, 2026
EPS Beat/Miss
+46.3%
Price Before
$20.90
Price After
$20.66
Q4 FY2025+1.69%
Report Date
Oct 21, 2025
EPS Beat/Miss
-160.0%
Price Before
$20.68
Price After
$21.03
Q3 FY2025+4.09%
Report Date
Jul 22, 2025
EPS Beat/Miss
+37.0%
Price Before
$30.29
Price After
$31.53
Q2 FY2025+1.72%
Report Date
Apr 22, 2025
EPS Beat/Miss
+4.3%
Price Before
$23.83
Price After
$24.24
Q1 FY2025-2.23%
Report Date
Feb 25, 2025
EPS Beat/Miss
+30.6%
Price Before
$32.69
Price After
$31.96
Q4 FY2024-1.63%
Report Date
Oct 22, 2024
EPS Beat/Miss
+14.3%
Price Before
$35.05
Price After
$34.48
Q3 FY2024-0.52%
Report Date
Jul 23, 2024
EPS Beat/Miss
-16.9%
Price Before
$46.20
Price After
$45.96
Avg Beat Reaction+0.76%
Avg Miss Reaction+0.58%
Beat Rate6 / 8 quarters
Largest Move+4.09% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: USNA ends December
USANA Health Sciences, Inc. (USNA) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.61 — beating the analyst consensus of $0.44 by +38.6%. USNA has beaten EPS estimates for 2 consecutive quarters. The next USNA earnings date is expected around September 1, 2026.
Each quarter, investors track USNA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. USNA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
USNA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
USNA earnings · 5 questionsUSANA Health Sciences, Inc.'s next earnings report is expected around September 1, 2026. USNA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; USNA historically reports after market close (AMC).
USNA earnings datewhen is USNA earningsUSNA next earnings datewhen does USNA report earningsUSNA earnings calendar
▸ Source: FMP · USANA Health Sciences, Inc. SEC filings · US GAAP · USANA Health Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026